These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19879767)

  • 1. Spare interactions of highly potent [Arg(14),Lys(15)]nociceptin for cooperative induction of ORL1 receptor activation.
    Isozaki K; Li J; Okada K; Nishimura H; Matsushima A; Nose T; Costa T; Shimohigashi Y
    Bioorg Med Chem; 2009 Dec; 17(23):7904-8. PubMed ID: 19879767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminatory synergistic effect of Trp-substitutions in superagonist [(Arg/Lys)(14), (Arg/Lys)(15)]nociceptin on ORL1 receptor binding and activation.
    Nishimura H; Li J; Isozaki K; Okada K; Matsushima A; Nose T; Costa T; Shimohigashi Y
    Bioorg Med Chem; 2009 Aug; 17(15):5683-7. PubMed ID: 19577933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly potent nociceptin analog containing the Arg-Lys triple repeat.
    Okada K; Sujaku T; Chuman Y; Nakashima R; Nose T; Costa T; Yamada Y; Yokoyama M; Nagahisa A; Shimohigashi Y
    Biochem Biophys Res Commun; 2000 Nov; 278(2):493-8. PubMed ID: 11097863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modelling of the ORL1 receptor and its complex with nociceptin.
    Topham CM; Moulédous L; Poda G; Maigret B; Meunier JC
    Protein Eng; 1998 Dec; 11(12):1163-79. PubMed ID: 9930666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of basic residues at positions 14-15 of nociceptin on binding affinity and receptor activation.
    Okada K; Isozaki K; Li J; Matsushima A; Nose T; Costa T; Shimohigashi Y
    Bioorg Med Chem; 2008 Oct; 16(20):9261-7. PubMed ID: 18818087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide.
    Shimohigashi Y; Hatano R; Fujita T; Nakashima R; Nose T; Sujaku T; Saigo A; Shinjo K; Nagahisa A
    J Biol Chem; 1996 Sep; 271(39):23642-5. PubMed ID: 8798582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two C-terminal amino acids, Ser(334) and Ser(335), are required for homologous desensitization and agonist-induced phosphorylation of opioid receptor-like 1 receptors.
    Wang HL; Kuo YL; Hsu CY; Huang PC; Li AH; Chou AH; Yeh TH; Chen YL
    Cell Signal; 2006 May; 18(5):670-8. PubMed ID: 16019191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An alternatively spliced transcript of the rat nociceptin receptor ORL1 gene encodes a truncated receptor.
    Xie G; Ito E; Maruyama K; Pietruck C; Sharma M; Yu L; Pierce Palmer P
    Brain Res Mol Brain Res; 2000 Apr; 77(1):1-9. PubMed ID: 10814826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct mechanisms for activation of the opioid receptor-like 1 and kappa-opioid receptors by nociceptin and dynorphin A.
    Mollereau C; Mouledous L; Lapalu S; Cambois G; Moisand C; Butour JL; Meunier JC
    Mol Pharmacol; 1999 Feb; 55(2):324-31. PubMed ID: 9927625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacement of Gln280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioids.
    Mollereau C; Moisand C; Butour JL; Parmentier M; Meunier JC
    FEBS Lett; 1996 Oct; 395(1):17-21. PubMed ID: 8849681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements of nociceptin antagonist Ac-RYYRIK-NH2 for receptor binding.
    Kawano C; Okada K; Honda T; Nose T; Sakaguchi K; Costa T; Shimohigashi Y
    J Pept Sci; 2002 Oct; 8(10):561-9. PubMed ID: 12450325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
    Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea PA; Regoli D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):270-7. PubMed ID: 10543428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capturing of the free cysteine residue in the ligand-binding site by affinity labeling of the ORL1 nociceptin receptor.
    Matsushima A; Nishimura H; Inamine S; Uemura S; Shimohigashi Y
    Bioorg Med Chem; 2011 Dec; 19(24):7597-602. PubMed ID: 22061823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro.
    Connor M; Vaughan CW; Chieng B; Christie MJ
    Br J Pharmacol; 1996 Dec; 119(8):1614-8. PubMed ID: 8982509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid activity profiles indicate similarities between the nociceptin/orphanin FQ and opioid receptors.
    Hawkinson JE; Acosta-Burruel M; Espitia SA
    Eur J Pharmacol; 2000 Feb; 389(2-3):107-14. PubMed ID: 10688973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nociceptin activation of the human ORL1 receptor expressed in Chinese hamster ovary cells: functional homology with opioid receptors.
    Fawzi AB; Zhang H; Weig B; Hawes B; Graziano MP
    Eur J Pharmacol; 1997 Oct; 336(2-3):233-42. PubMed ID: 9384238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides.
    Lapalu S; Moisand C; Mazarguil H; Cambois G; Mollereau C; Meunier JC
    FEBS Lett; 1997 Nov; 417(3):333-6. PubMed ID: 9409745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tritium-labelled isovaleryl-RYYRIK-NH2 as potential antagonist probe for ORL1 nociceptin receptor.
    Inamine S; Nishimura H; Li J; Isozaki K; Matsushima A; Costa T; Shimohigashi Y
    Bioorg Med Chem; 2014 Nov; 22(21):5902-9. PubMed ID: 25284251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nociceptin and the ORL1 receptor: pharmacology of a new opioid receptor].
    Grond S; Meuser T; Pietruck C; Sablotzki A
    Anaesthesist; 2002 Dec; 51(12):996-1005. PubMed ID: 12486589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct identification of a peptide binding region in the opioid receptor-like 1 receptor by photoaffinity labeling with [Bpa(10),Tyr(14)]nociceptin.
    Moulédous L; Topham CM; Mazarguil H; Meunier JC
    J Biol Chem; 2000 Sep; 275(38):29268-74. PubMed ID: 10880520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.